Skip to content Skip to sidebar Skip to footer
Subscribe Now
Viewpoints_Mike Crichton
VIEWPOINTS

PharmaShots Interview: GSK’s Mike Crichton Shares Insights on the Approval of Benlysta in Europe

In an interview with PharmaShots, Mike Crichton, Senior Vice President, Global Therapy Area Head, Specialty & Primary Care at GSK shares his views on the European Commission's approval of Benlysta (belimumab) in combination with background immunosuppressive therapies for the treatment of adult patients with active lupus nephritis (LN).Shots:The European Commission approved the expanded use of GSK's…
June 8, 20210Comments

Read more

Viewpoints_Dr. Gill Diamond and Joshua McClure
VIEWPOINTS

PharmaShots Interview: Maxwell Biosciences’ Dr. Gill Diamond and Joshua McClure Share Insights Novel Peptoids with Potent Antiviral Activity Against HSV-1 and SARS-CoV-2

In an interview with PharmaShots, Dr. Gill Diamond, Scientific Advisory Board Member and Joshua McClure, CEO and Co-founder of Maxwell Biosciences share their views on the news findings of the company published in MDI that demonstrated that several peptoids exhibit potent in vitro antiviral activity against both HSV-1 and SARS-CoV-2.Shots:The studies showed that antiviral peptoids…
June 7, 20210Comments

Read more

Viewpoints_Rich Colvin
VIEWPOINTS

PharmaShots Interview: bluebird bio’s Rich Colvin Shares Insights on the Skysona to Treat Early Cerebral Adrenoleukodystrophy

In an interview with PharmaShots, Rich Colvin, M.D., Ph.D., Interim Chief Medical Officer at bluebird bio shares his views on the Skysona and its working on CALD patients.Shots:If granted marketing authorization, Skysona would be the first approved one-time gene therapy for CALD which is a rare neurogenerative disease with typically childhood onsetThe CHMP opinion…
June 4, 20210Comments

Read more

Viewpoints_Ken Keller
VIEWPOINTS

PharmaShots Interview: Daiichi Sankyo’s Ken Keller Shares Insights on NICE Recommendation for Enhertu in HER2 Positive Breast Cancer

In an interview with PharmaShots, Ken Keller, President and Chief Executive Officer at Daiichi Sankyo and Global Head of the Daiichi Sankyo Oncology Business shared his views on the NICE CDF recommendation for Enhertu in unresectable or metastatic HER2 positive breast cancer and the company's growth and pipeline.Shots:The recommendation from NICE is based on the…
June 2, 20210Comments

Read more

Viewpoints_Neil Solomons
VIEWPOINTS

PharmaShots Interview: Aurinia’s Neil Solomons Shares Insights on the Lupkynis

In an interview with PharmaShots, Neil Solomons, Co-founder and Chief Medical Officer of Aurinia shared his views on the data of Lupkynis (voclosporin) presented at the National Kidney Foundation 2021 Spring Clinical Meetings.Shots:New data analysis from the AURORA and AURA clinical studies shows that Aurinia's therapy demonstrated efficacy across all LN biopsy classes. These data show that treatment…
June 1, 20210Comments

Read more

Viewpoints_Neil Moat
VIEWPOINTS

PharmaShots Interview: Abbott’s Neil Moat Shares Insights on the Next Generation TriClip Transcatheter Tricuspid Valve Repair System

In an interview with PharmaShots, Neil Moat, M.D., Chief Medical Officer of Abbott's Structural Heart Business shares his views on the CE mark approval of first-of-its-kind TriClip device.Shots:The new iteration of the device, called TriClip G4, offers new clip sizes and an enhanced leaflet grasping feature for physicians to further customize treatment to the complex tricuspid valve…
May 31, 20210Comments

Read more

Thoughtspot_Parshuram Nivrutti
THOUGHTSPOT

Recent Insights into Advances of COVID-19 Treatment

Introduction:The current century has witnessed the universal spread of the unknown species of coronaviruses. The rapid deterioration of the public health system with changes in ecology and urbanization has accelerated more recurrent epidemics, which become more troublesome to prevent and contain promptly. A novel coronavirus (CoV) emerged in December 2019, is associated with respiratory…
May 27, 20210Comments

Read more

Viewpoints_Dr. Fahar Merchant
VIEWPOINTS

PharmaShots Interview: Medicenna’s Dr. Fahar Merchant Shares Insights on the Bispecific Superkines

In an interview with PharmaShots, Dr. Fahar Merchant, CEO of Medicenna shares his views on the data of a new type of interleukin called bispecific Superkines, presented at AACR 2021  Shots:Bispecific Superkines can attack cold tumors, weakening the protection given to it by the tumor microenvironment and revealing it to the immune systemMedicenna focuses on…
May 26, 20210Comments

Read more

Viewpoints_Anthony Costello
VIEWPOINTS

PharmaShots Interview: Medidata’s Anthony Costello Shares Insights on the Transformative Sensor Cloud Platform for Connected Devices and Wearable Sensors in Clinical Trials

In an interview with PharmaShots, Anthony Costello, President, Patient Cloud at Medidata share his views on the launch of Sensor Cloud which is a transformative platform for managing a sensor and digital health technology data during the clinical trials.Shots:The company launches Sensor Cloud for managing sensor and digital health technology data during the clinical trial.…
May 25, 20210Comments

Read more